Diffuse Large B-cell lymphoma |
hsa-miR-21 |
OCI-Ly1, OCI-Ly18, SU-DHL-7 |
Up |
PI3K-Akt signaling pathway |
miR-21 plays an important oncogenic role by down regulating the expression of PTEN and modulating the PI3K-Akt signaling pathway in Diffuse Large B-cell lymphoma. |
Go et al., 2015 |
Diffuse Large B-cell lymphoma |
hsa-miR-21 |
OCI-Ly1, OCI-Ly18, SU-DHL-7 |
Up |
mTOR pathway |
miR-21 plays an important oncogenic role by down regulating the expression of PTEN and modulating the mTOR pathway in Diffuse Large B-cell lymphoma. |
Go et al., 2015 |
Nasal natural killer cell lymphoma |
hsa-miR-494 |
YT, NK-92 |
Up |
PI3K-Akt signaling pathway |
hsa-miR-494 suppresses the expression of PTEN with secondary induction of AKT. The PI3K-Akt signaling pathway is critical in the pathogenesis of Nasal natural killer cell lymphoma. |
Chen et al., 2015 |
Sezary syndrome |
hsa-miR-106b |
HuT 78, H9, HH |
Up |
PI3K-Akt signaling pathway |
Overexpression of hsa-miR-106b downregulates the expression of PTEN. Reduced PTEN activates the PI3/AKT-mediated pathway of cell growth and survival. |
Cristofoletti et al., 2013 |
Sezary syndrome |
hsa-miR-21 |
HuT 78, H9, HH |
Up |
PI3K-Akt signaling pathway |
Overexpression of hsa-miR-21 downregulates the expression of PTEN. Reduced PTEN activates the PI3/AKT-mediated pathway of cell growth and survival. |
Cristofoletti et al., 2013 |
Sezary syndrome |
hsa-miR-486 |
HuT 78, H9, HH |
Up |
PI3K-Akt signaling pathway |
Overexpression of hsa-miR-486 downregulates the expression of PTEN. Reduced PTEN activates the PI3/AKT-mediated pathway of cell growth and survival. |
Cristofoletti et al., 2013 |
Diffuse Large B-cell lymphoma |
hsa-miR-21 |
CRL2631 |
Up |
PI3K-Akt signaling pathway |
hsa-miR-21 regulates the PI3K-Akt signaling pathway through the regulation of PTEN, thereby affecting cellular sensitivity to the CHOP chemotherapeutic regimen. |
Bai et al., 2013 |
Mantle cell lymphoma |
hsa-miR-17-92 cluster |
Z-138, Granta-519, JeKo-1 |
Up |
PI3K-Akt signaling pathway |
Overexpression of miR-17-92 cluster activates the PI3K-Akt signaling pathway through targeting PTEN and inhibites chemotherapy-induced apoptosis in mantle cell lymphoma. |
Rao et al., 2012 |
Chronic lymphocytic leukemia |
hsa-miR-22 |
Peripheral blood |
Up |
PI3K-Akt signaling pathway |
Up-regulation of microRNA-22 is associated with suppression of phosphatase and tensin homolog (PTEN) and phosphoinositide 3-kinase (PI3K)/PI3K-Akt signaling pathway activation in chronic lymphocytic leukemia. |
Palacios et al., 2015 |
Alzheimer's disease |
hsa-miR-132 |
Cerebral cortex |
Down |
PI3K-Akt signaling pathway |
MicroRNA-132 regulates cell survival by direct suppression of PTEN, which is the key elements of AKT signaling pathway. |
Wong et al., 2013 |
Alzheimer's disease |
hsa-miR-212 |
Cerebral cortex |
Down |
PI3K-Akt signaling pathway |
MicroRNA-212 regulates cell survival by direct suppression of PTEN, which is the key elements of AKT signaling pathway. |
Wong et al., 2013 |
Gastric cancer |
hsa-miR-21 |
Gastric cancer tissue |
Up |
PI3K-Akt signaling pathway |
MicroRNA-21 enhances the phosphorylation of Akt through dropping PTEN which promotes the epithelial-mesenchymal transition in gastric cancer induced by TGF-beta 1. |
Liet al., 2016 |
Gastric cancer |
hsa-miR-370 |
Gastric cancer tissue |
Up |
PTEN pathway |
MicroRNA-370 down-regulates PTEN, leads to activation of apoptosis signaling and the cell proliferation of cervical cancer cells, ameliorates gastric cancer growth and progression. |
Zeng et al., 2016 |
Gastric cancer |
hsa-miR-106a |
SGC-7901 |
Up |
PI3K-Akt signaling pathway |
MicroRNA-106a regulates cisplatin resistance in gastric cancer cells by targeting PI3K-Akt signaling pathway. |
Fang et al., 2013 |
Gastric cancer |
hsa-miR-21 |
SGC-7901 |
Up |
PI3K-Akt signaling pathway |
hsa-miR-21 promotes cell survival and cisplatin resistance in gastric cancer through inhibiting phosphatase and tension homolog deleted on chromosome 10 (PTEN) expression level and activation of PI3K-Akt signaling pathway. |
Yang et al., 2013 |
Laryngeal squamous cell carcinoma |
hsa-miR-744 |
Lung |
Up |
mTOR pathway |
Down-regulation of miR-744 is associated with suppression of laryngeal squamous cell carcinoma metastasis by inactivating AKT/mTOR signaling pathway. |
Li et al., 2016 |
Non-small cell lung cancer |
hsa-miR-10a |
Lung |
Up |
PI3K-Akt signaling pathway |
Upregulation of miR-10a enhances non-small cell lung cancer cell proliferation, migration and invasion through targeting PTEN. |
Yu et al., 2015 |
Non-small cell lung cancer |
hsa-miR-494 |
HUVEC |
|
PI3K-Akt signaling pathway |
MicroRNA-494 regulates angiogenesis by down-regulating PTEN and activates PI3K-Akt signaling pathway. |
Mao et al., 2015 |
Non-small cell lung cancer |
hsa-miR-21 |
Lung |
Up |
NF-Kappa B signaling pathway |
Suppression of NF-Kappa B signaling pathway enhances cisplatin sensitivity in non-small cell lung cancer. |
Yang et al., 2015 |
Breast cancer |
hsa-miR-29a |
Breast |
Up |
PI3K-Akt signaling pathway |
MicroRNA-29a promotes adriamycin resistance via PTEN/AKT/GSK3-beta pathway through targeting PTEN in breast cancer cells. |
Shen et al., 2016 |
Breast cancer |
hsa-miR-10b |
MCF-7,MDA-MB-231, SK-BR-3 |
Up |
PI3K-Akt signaling pathway |
MicroRNA-10b regulates the self-renewal of the breast cancer stem cell phenotype through PI3K-Akt signaling pathway by targeting PTEN. |
Bahena-Ocampo et al., 2016 |
Breast cancer |
hsa-miR-214 |
Breast |
Up |
PI3K-Akt signaling pathway |
MicroRNA-214 functions as oncogene in breast cancer by inhibiting the PI3K-Akt signaling pathway. |
Wang et al., 2016 |
Breast cancer |
hsa-miR-21 |
MCF-7 |
|
PI3K-Akt signaling pathway |
MiR-21 regulates autophagy and apoptosis by suppression phosphatase and tensin homolog (PTEN) through targeting PI3K-Akt signaling pathway. |
Yu et al., 2016 |
Breast cancer |
hsa-miR-21 |
4T1 |
Up |
PI3K-Akt signaling pathway |
MicroRNA-21 functions as a fine tuner in the regulation of PI3K-Akt signaling pathway in the expansion of CCR6(+) Tregs in tumor sites. |
Hu et al., 2015 |
Hepatocellular carcinoma |
hsa-miR-21 |
Hepatocyte |
Up |
PI3K-Akt signaling pathway |
Overexpression of hsa-miR-21 reduces PTEN expression and sequential Akt activation. It suppresses autophagy through PI3K-Akt signaling pathway. |
He et al., 2015 |
Glioblastoma |
hsa-miR-1908 |
SW1783, SW1088, SNB-19 |
Up |
PTEN pathway |
Overexpression of hsa-miR-1908 inhibits the expression of PTEN. miR-1908 acts as oncogene through repressing PTEN pathway. |
Xia et al., 2015 |
Hepatocellular carcinoma |
hsa-miR-20a |
Hepatocyte |
Up |
PI3K-Akt signaling pathway |
Overexpression of hsa-miR-20a downregulates PTEN expression. Mir-20a promotes HCC cell radioresistance by activating the PTEN/PI3K-Akt signaling pathway. |
Zhang et al., 2015 |
Hepatocellular carcinoma |
hsa-miR-429 |
Hepatocyte |
|
PI3K-Akt signaling pathway |
Overexpression of hsa-miR-429 directly targets PTEN expression. hsa-miR-429 promotes HCC cell migration and invasion through PI3K-Akt signaling pathway. |
Tang et al., 2015 |
Hepatocellular carcinoma |
hsa-miR-32 |
Hepatocyte |
Up |
PI3K-Akt signaling pathway |
hsa-miR-32 promotes hepatocellular carcinoma cell proliferation, migration and invasion via PI3K-Akt signaling pathway through targeting PTEN. |
Yan et al., 2015 |
Hepatocellular carcinoma |
hsa-miR-93 |
Hepatocyte |
Up |
PI3K-Akt signaling pathway |
hsa-miR-93 suppresses the expression of PTEN, thereby regulating hepatocellular carcinoma cell apoptosis and c-Met/PI3K-Akt signaling pathway activity. |
Ohta et al., 2015 |
Cervical cancer |
hsa-miR-130a |
HeLa, Ca Ski |
|
NF-Kappa B signaling pathway |
Overexpression of microRNA-130a regulates cervical cancer cell growth by inhibiting phosphatase and tensin homolog expression. |
Feng et al., 2016 |
Cervical cancer |
hsa-miR-221 |
HeLa, SiHa |
Up |
PI3K-Akt signaling pathway |
MicroRNA-221 decreases the sensitivity of cervical cancer cells to gefitinib via the PI3K-Akt signaling pathway. |
Du et al., 2016 |
Cervical cancer |
hsa-miR-21 |
HeLa, Ca Ski |
Up |
PTEN pathway |
MicroRNA-21 induces proliferation, migration and invasion in cervical cancer cells through targeting the PTEN expression. |
Xu et al., 2015 |
Cervical cancer |
hsa-miR-494 |
HeLa, Ca Ski, SiHa |
Up |
PI3K-Akt signaling pathway |
MicroRNA-494 enhances proliferation of cervical cancer through targeting PTEN expression. |
Yang et al., 2015 |
Prostate cancer |
hsa-miR-4534 |
DU145 |
Up |
PTEN pathway |
MicroRNA-4534 functions as an oncogenic microRNA and regulates PTEN pathway in prostate cancer. |
Nip et al., 2016 |
Nasopharyngeal carcinoma |
hsa-miR-92a |
CNE-1, CNE-2 |
Up |
PI3K-Akt signaling pathway |
MicroRNA-92a induces metastasis of nasopharyngeal carcinoma by down-regulating the PI3K-Akt signaling pathway. |
Zhang et al., 2016 |
Nasopharyngeal carcinoma |
hsa-miR-141 |
HNE-1 |
Up |
PI3K-Akt signaling pathway |
MicroRNA-141 promotes cell proliferation and tumor formation in nasopharyngeal carcinoma through targeting PI3K-Akt signaling pathway. |
Liu et al., 2016 |
Osteosarcoma |
hsa-miR-21 |
MG-63 |
Up |
PI3K-Akt signaling pathway |
MicroRNA-21 plays an active role in osteosarcoma through PI3K-Akt signaling pathway by inhibiting PTEN expression. |
Lv et al., 2016 |
Asthma |
hsa-miR-21 |
Airway smooth muscle |
Up |
PI3K-Akt signaling pathway |
MicroRNA-21 enhanced proliferation and migration of human airway smooth muscle (HASM) cell in asthma through activation of phosphoinositide 3 kinase pathway. |
Liu et al., 2015 |
Atherosclerosis |
hsa-miR-221 |
HUVEC |
|
PTEN pathway |
MiR-221 from human aortic smooth muscle cell-derived exosomes inhibits autophagy in HUVECs by modulating PTEN signaling pathway. |
Li et al., 2016 |
Atherosclerosis |
hsa-miR-222 |
HUVEC |
|
PTEN pathway |
MiR-221 from human aortic smooth muscle cell-derived exosomes inhibits autophagy in HUVECs by modulating PTEN signaling pathway. |
Li et al.,2016 |
Psoriasis |
hsa-miR-155 |
HaCat |
Up |
PTEN pathway |
Decreased expression of miR-155 significantly inhibits proliferation, migration, invasion and promotes apoptosis through PTEN singaling pathway in psoriasis cells. |
Xu et al., 2017 |